Abstract:Background/Aims: Osteonecrosis of the femoral head (ONFH) is a devastating orthopedic disease. Previous studies suggested that stromal-cell-derived factor (SDF)-1 was involved in osteogenesis and angiogenesis. However, whether SDF-1 potentiates the angiogenesis and osteogenesis of bone marrow-derived stromal stem cells (BMSCs) in ONFH is not clear. Methods: BMSCs were transfected with green fluorescent protein (GFP) or the fusion gene encoding GFP and SDF-1α, and transgenic efficacy was monitored by immunofluorescence. The expression of SDF-1α, runt-related transcription factor 2 (Runx2, osteocalcin (OCN), and alkaline phosphatase (ALP) at the mRNA level was measured by real-time polymerase chain reactions (RT-PCR). The expression of SDF-1α, Runx2, OCN, and p-Smad1/5 were measured at the protein level by Western blot. Transwell migration assay and tube formation assay were utilized to detect the angiogenesis in vitro, whereas the in vivo angiogenesis was monitored by angiography. Immunohistological staining and micro-CT scanning were conducted to assess the histological changes in morphology. Results: In vitro, SDF-1α overexpression in BMSCs promoted osteogenic differentiation and upregulated the expression of osteogenic-related proteins, such as ALP, Runx2, OCN, and p-Smadl/5. In the methylprednisolone induced ONFH rat model used in our investigation, the overexpression of SDF-1α in BMSCs promoted significantly more bone regeneration and the expression of OCN and Runx2 as compared with the effect of vehicle overexpression. Moreover, the morphology of ONFH was ameliorated after the transplantation of BMSCs with SDF-1α overexpression. Furthermore, SDF-1α overexpression in BMSCs significantly increased osteoblastic angiogenesis as indicated by the increased tube formation ability, CD31 expression, and vessel volume. Conclusion: SDF-1α overexpression in BMSCs promotes bone generation as indicated by osteogenesis and angiogenesis, suggesting SDF-1α may serve as a therapeutic drug target for ONFH treatment.

Stromal cell derived factor-1α promotes the migration, proliferation, and osteogenic differentiation of mouse bone marrow mesenchymal stem cells via the Wnt/β-catenin pathway.

Fluid shear stress promotes osteogenesis of bone mesenchymal stem cells at early matrix maturity phase through Lamin A/ METTL3 signal axis

Bone marrow mesenchymal stem cells overexpressing stromal cell- derived factor 1 aid in bone formation in osteoporotic mice

Stromal-derived Factor-1 Promotes the Growth, Survival, and Development of Human Bone Marrow Stromal Stem Cells

Stromal cell-derived factor-1-directed bone marrow mesenchymal stem cell migration in response to inflammatory and/or hypoxic stimuli

Stromal cell-derived factor-1 enhances wound healing through recruiting bone marrow-derived mesenchymal stem cells to the wound area and promoting neovascularization.

Stromal-Cell-Derived Factor (SDF) 1-Alpha Overexpression Promotes Bone Regeneration by Osteogenesis and Angiogenesis in Osteonecrosis of the Femoral Head

SDF-1α Induces Differentiation of Rat Bone Marrow Stem Cells

Stromal cell-derived factor-1 promotes osteoblastic differentiation of human bone marrow mesenchymal stem cells via the lncRNA-H19/miR-214-5p/BMP2 axis

Stromal-derived Factor-1α signaling is involved in bone morphogenetic protein-2-induced odontogenic differentiation of stem cells from apical papilla via the Smad and Erk signaling pathways

Overexpression of Bone Morphogenetic Protein-1 Promotes Osteogenesis of Bone Marrow Mesenchymal Stem Cells in Vitro

Migration Critically Meditates Osteoblastic Differentiation of Bone Mesenchymal Stem Cells Through Activating Canonical Wnt Signal Pathway.

A Preliminary Study of SDF-1 in Stem Cell Homing-guided Tissue Regeneration

Effects of BMP2 and VEGF165 on the Osteogenic Differentiation of Rat Bone Marrow-Derived Mesenchymal Stem Cells.

The Differential Effect of Basic Fibroblast Growth Factor and Stromal Cell‑derived Factor‑1 Pretreatment on Bone Morrow Mesenchymal Stem Cells Osteogenic Differentiation Potency.

The effect of simvastatin on chemotactic capability of SDF-1α and the promotion of bone regeneration.

Anti-Angiogenesis Therapy Based on the Bone Marrow-Derived Stromal Cells Genetically Engineered to Express Sflt-1 in Mouse Tumor Model

Bone Marrow Stromal Cells Stimulated by Strontium-Substituted Calcium Silicate Ceramics: Release of Exosomal Mir-146A Regulates Osteogenesis and Angiogenesis.

Stromal Cell-Derived Factor-1Α and Transforming Growth Factor-Β1 Synergistically Facilitate Migration and Chondrogenesis of Synovium-Derived Stem Cells Through MAPK Pathways.

Effect of DKK-1 gene scilence mediated by siRNA lentivirus vector on the differentiation of bone marrow mesenchymal stem cells

Overexpression of HSPA1A Enhances the Osteogenic Differentiation of Bone Marrow Mesenchymal Stem Cells Via Activation of the Wnt/β-catenin Signaling Pathway.